BioNTech founders to speak among 50 other tech leaders at EmTech Europe conference

Taking ‘Forging a Brighter Future’ as its theme in this year, MIT Technology Review’s flagship conference ‘EmTech Europe’ will bring 50 of Europe’s brightest and best technology leaders, researchers and innovators together to discuss how technology can create an intelligent, healthy and sustainable future.

By Claire Cartmill
Thursday, 27th May 2021, 6:00 am
Co-Founder of BionNTech Dr Ugur Sahin who initiaited ‘Project Lightspeed’ the historic development program of the first mRNA-based vaccine for Covid-19
Co-Founder of BionNTech Dr Ugur Sahin who initiaited ‘Project Lightspeed’ the historic development program of the first mRNA-based vaccine for Covid-19

Playing a crucial role in addressing the pandemic in the last year with their breakthrough messenger RNA (mRNA) technology, the founders of BioNTech will headline this year’s EmTech Europe virtual conference in Belfast on July 1.

Dr. Ugur Sahin and Dr. Özlem Türeci, the husband-and-wife team behind BioNTech, developed the mRNA-based vaccine technology that delivered the first Covid-19 vaccine with completed phase 3 trial when the pandemic hit.

Dr Sahin initiated and led ‘Project Lightspeed’, the historic development program of the first mRNA-based vaccine for Covid-19, moving from lab and clinical testing to conditional authorisations within an unprecedented 11-month period. He also leads BioNTech’s research and development of individualized cancer immunotherapies.

Sign up to our daily newsletter

Dr. Ozlem Tureci, Co-Founder of BioNTech and Clinical Lead for the development of the mRNA-based Covid-19 vaccine

Dr Türeci played a crucial role in the clinical development of ‘Project Lightspeed’ and helped lead the development of mRNA-based vaccines and cancer antigens as well as immunotherapies which are currently in clinical development.

The globally-renowned scientists’ opening keynote will address the conference theme ‘Forging a Brighter Future’ and spell out their motivation and vision for expanding the use of mRNA technology to address other diseases in the future.

Drs Sahin and Türeci will address day one of the conference which takes place virtually from Belfast on July 1-2. They join a line up of some of Europe’s most brilliant tech minds across the fields of sustainability, health and artificial intelligence.

Nico Crepaldi, Head of Custom Content at MIT Technology Review, said: “Attendees of EmTech Europe 2021 will get to hear from 50 leading speakers who are driving the next generation of technological advances. With talks ranging from the first timber skyscraper in Europe to biomedicine and mRNA vaccines, as well as spotlights from past winners of our Innovators Under 35 competition, EmTech Europe 2021 will showcase innovative solutions addressing major global issues.”

Connla McCann, Director of EmTech Europe, continued: “Through EmTech Europe, Belfast can showcase the progress it has made from a city associated with conflict and division to a city focused on forging a new path of peace and reconciliation underpinned by an inclusive knowledge economy.”

Lead Curator of EmTech Europe, Tom Gray, added: “We are thrilled to have the BioNTech founders join our dynamic list of speakers for EmTech Europe this July. A clear leader in individually tailored therapies, BioNTech’s addition will only serve to enhance the programme as we prepare to highlight the practitioners, and thought leaders, at the forefront of ground-breaking technological advancements.

“EmTech Europe 2021 will spark new ideas and business opportunities around the innovative trends with the most power to influence the post-pandemic world. Examining the areas of health, sustainability and intelligence, the two-day programme is shaping up to be a must-attend event for technological leaders seeking to rebuild economies and societies.”

EmTech Europe is supported by Belfast City Council and Invest NI and will take place virtually in July before returning to Belfast in 2022 and 2023.

A message from the Editor:

Thank you for reading this story on our website. While I have your attention, I also have an important request to make of you.

In order for us to continue to provide high quality and trusted local news on this free-to-read site, I am asking you to also please purchase a copy of our newspaper whenever you are able to do so.

Our journalists are highly trained and our content is independently regulated by IPSO to some of the most rigorous standards in the world. But being your eyes and ears comes at a price. So we need your support more than ever to buy our newspapers during this crisis.

With the coronavirus lockdown having a major impact on many of our local valued advertisers - and consequently the advertising that we receive - we are more reliant than ever on you helping us to provide you with news and information by buying a copy of our newspaper when you can safely.

You can also enjoy unlimited access to the best news from across Northern Ireland and the UK by subscribing to

With a digital subscription, you can read more than five articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Visit now to sign up.

Thank you